RhoA-Rho kinase and platelet-activating factor stimulation of ovine foetal pulmonary vascular smooth muscle cell proliferation
- 22 August 2013
- journal article
- Published by Wiley in Cell Proliferation
- Vol. 46 (5), 563-575
- https://doi.org/10.1111/cpr.12052
Abstract
Platelet-activating factor (PAF) is produced by pulmonary vascular smooth muscle cells (PVSMC). We studied effects of Rho kinase on PAF stimulation of PVSMC proliferation in an attempt to understand the role of RhoA/Rho kinase on PAF-induced ovine foetal pulmonary vascular remodelling. Our hypothesis is that PAF acts through Rho kinase, as one of its downstream signals, to induce arterial (SMC-PA) and venous (SMC-PV) cell proliferation in the hypoxic lung environment of the foetus, in utero. Rho kinase and MAPK effects on PAF receptor (PAFR)-mediated cell population expansion, and PAFR expression, were studied by DNA synthesis, western blot analysis and immunocytochemistry. Effects of constructs T19N and G14V on PAF-induced cell proliferation were also investigated. Hypoxia increased PVSMC proliferation and Rho kinase inhibitors, Y-27632 and Fasudil (HA-1077) as well as MAPK inhibitors PD 98059 and SB 203580 attenuated PAF stimulation of cell proliferation. RhoA T19N and G14V stimulated cell proliferation, but co-incubation with PAF did not affect proliferative effects of the constructs. PAFR protein expression was significantly downregulated in both cell types by both Y-27632 and HA-1077, with comparable profiles. Also, cells treated with Y-27632 had less PAF receptor fluorescence with significant disruption of cell morphology. Our results show that Rho kinase non-specifically modulated PAFR-mediated responses by a translational modification of PAFR protein, and suggest that, in vivo, activation of Rho kinase by PAF may be a further pathway to sustain PAFR-mediated PVSMC proliferation.Keywords
This publication has 47 references indexed in Scilit:
- Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cellsOncology Letters, 2013
- Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathwaysJournal of Vascular Surgery, 2012
- Rescue of internalization-defective platelet-activating factor receptor function by EBP50/NHERF1Journal of Cell Communication and Signaling, 2012
- Prolonged hypoxia modulates platelet activating factor receptor-mediated responses by fetal ovine pulmonary vascular smooth muscle cellsMolecular Genetics and Metabolism, 2010
- Rho kinase modulates postnatal adaptation of the pulmonary circulation through separate effects on pulmonary artery endothelial and smooth muscle cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problemCurrent Opinion in Pharmacology, 2009
- COMMON PATHWAYS FOR ACTIVATION OF PROINFLAMMATORY GENE EXPRESSION BY G PROTEIN–COUPLED RECEPTORS IN PRIMARY LUNG EPITHELIAL AND ENDOTHELIAL CELLSExperimental Lung Research, 2009
- Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized ratAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lungAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Effects of endothelin, platelet activating factor and thromboxane A2 in ferret lungsRespiration Physiology, 1992